|
|
||||||||
David H. Smith Center for Vaccine Biology and Immunology, Aab Institute for Biomedical Sciences, University of Rochester Medical Center, Rochester, NY 14642
Mammalian TLRs are understood primarily as an activating system for innate and adaptive immunity, but have also been implicated in sensing cellular damage and in promoting intestinal integrity. In this study we show that TLR-4 also controls the in vivo distribution of activated CD8+ T cells. The liver is a site for trapping and apoptosis of activated CD8+ T cells during systemic immune responses, but the reason for this is unknown. In this study we tested the hypothesis that the livers constant exposure to endotoxin, derived from commensal bacteria in the gut, acts via TLR-4 to promote activated T cell adhesion. In the absence of TLR-4, the liver was compromised in its ability to sequester activated CD8+ T cells, and there was an inverse correlation between the frequency of activated CD8+ T cells trapped in the liver and their frequency in the circulating pool. Thus, in the absence of any inflammation, TLR-4 ligands play a significant role in the ability of the liver to trap activated CD8+ T cells. This provides a new perspective on the regulation of immune responses by TLR-4 under basal conditions.
This article has been cited by other articles:
![]() |
G Ahlen, E Derk, M Weiland, J Jiao, N Rahbin, S Aleman, D L Peterson, K Pokrovskaja, D Grander, L Frelin, et al. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes Gut, April 1, 2009; 58(4): 560 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasarathy Inflammation and Liver JPEN J Parenter Enteral Nutr, November 1, 2008; 32(6): 660 - 666. [Full Text] [PDF] |
||||
![]() |
K. A. Daly, C. Lefevre, K. Nicholas, E. Deane, and P. Williamson CD14 and TLR4 are expressed early in tammar (Macropus eugenii) neonate development J. Exp. Biol., April 15, 2008; 211(8): 1344 - 1351. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |